Mutations in TP53 are important for the diagnostics of several glioma subtypes: IDH-mutant astrocytoma, H3 K27-altered diffuse midline glioma, H3 G34-mutant diffuse hemispheric glioma and SHH-activated medulloblastoma [3]. Here, TP53 is linked to central nervous system cancer.